Stryker/$SYK
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Ticker
$SYK
Sector
Primary listing
NYSE
Employees
53,000
Headquarters
Website
Stryker Metrics
BasicAdvanced
$150B
52.07
$7.55
0.91
$3.32
0.85%
Price and volume
Market cap
$150B
Beta
0.91
52-week high
$406.19
52-week low
$329.16
Average daily volume
1.3M
Dividend rate
$3.32
Financial strength
Current ratio
1.784
Quick ratio
0.876
Long term debt to equity
71.814
Total debt to equity
80.827
Dividend payout ratio (TTM)
42.87%
Interest coverage (TTM)
13.35%
Profitability
EBITDA (TTM)
6,388
Gross margin (TTM)
64.95%
Net profit margin (TTM)
12.25%
Operating margin (TTM)
22.20%
Effective tax rate (TTM)
12.92%
Revenue per employee (TTM)
$450,000
Management effectiveness
Return on assets (TTM)
7.73%
Return on equity (TTM)
14.25%
Valuation
Price to earnings (TTM)
52.067
Price to revenue (TTM)
6.3
Price to book
7.09
Price to tangible book (TTM)
-38
Price to free cash flow (TTM)
37.288
Free cash flow yield (TTM)
2.68%
Free cash flow per share (TTM)
10.544
Dividend yield (TTM)
0.84%
Forward dividend yield
0.85%
Growth
Revenue change (TTM)
11.36%
Earnings per share change (TTM)
-15.81%
3-year revenue growth (CAGR)
10.55%
10-year revenue growth (CAGR)
9.27%
3-year earnings per share growth (CAGR)
11.62%
10-year earnings per share growth (CAGR)
11.96%
3-year dividend per share growth (CAGR)
6.94%
10-year dividend per share growth (CAGR)
9.50%
What the Analysts think about Stryker
Analyst ratings (Buy, Hold, Sell) for Stryker stock.
Stryker Financial Performance
Revenues and expenses
Stryker Earnings Performance
Company profitability
Stryker News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept30
Stryker
Dividend·Ex-dividend
Oct31
Stryker
Dividend·Payment
$0.84Per share
FAQs
What’s the current market cap for Stryker stock?
Stryker (SYK) has a market cap of $150B as of August 29, 2025.
What is the P/E ratio for Stryker stock?
The price to earnings (P/E) ratio for Stryker (SYK) stock is 52.07 as of August 29, 2025.
Does Stryker stock pay dividends?
Yes, the Stryker (SYK) stock pays dividends to shareholders. As of August 29, 2025, the dividend rate is $3.32 and the yield is 0.85%. Stryker has a payout ratio of 42.87% on a trailing twelve-month basis.
When is the next Stryker dividend payment date?
The next Stryker (SYK) dividend payment is scheduled for October 31, 2025.
What is the beta indicator for Stryker?
Stryker (SYK) has a beta rating of 0.91. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.